@incollection{, 62B24AAAF36F825DD29E1B7755BBBC03 , author={{Delfina R. Msanga, Raphael Rwezaula, Semvua Kilonzo, Elizabeth Kwiyolecha, Tulla Masoza, Emmanuel Mkumbo, Mariam M. Mirambo, Stephen E.Mshana} and {Catholic University of Health and Allied Sciences}}, journal={{Global Journal of Medical Research}}, journal={{GJMR}}2249-46180975-588810.34257/GJMR, address={Cambridge, United States}, publisher={Global Journals Organisation}2052531 } @book{b0, , title={{Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging}} , author={{ DLavanchy }} } @book{b1, , title={{}} , author={{ AJafarzadeh } and { Sajadi S: Persistence Of Anti-Hbs Antibodies In Healthy Iranian Children Vaccinated With Recombinanthepatitis B Vaccine And ResponseTo A Booster } and { Dose }} , year={2005} } @incollection{b2, , title={{Efficacy of a mass hepatitis B immunization program after switching to recombinant hepatitis B vaccine: a population-based study in Taiwan}} , author={{ H-MHsu } and { S-CLee } and { M-CWang } and { S-FLin } and { D-SChen }} , journal={{Vaccine}} 19 20 , year={2001} } @book{b3, , title={{Evaluation of the immune response to hepatitis B vaccination in children aged 1-3 years in Malatya, Turkey. The new microbiologica}} , author={{ LKaraoglu } and { EPehlivan } and { GGunes } and { MGenc } and { STekerekoglu } and { CErcan } and { MEgri } and { SYologlu }} , year={2003} 26 } @book{b4, , title={{WHO: Hepatitis B position paper}} , year={2017} } @incollection{b5, , title={{Persistence of antibody to hepatitis B surface antigen among vaccinated children in a low hepatitis B virus endemic area}} , author={{ AAghakhani } and { MBanifazl } and { NIzadi } and { WMcfarland } and { MSofian } and { AKhadem-Sadegh } and { ZPournasiri } and { MForoughi } and { AEslamifar } and { ARamezani }} , journal={{World Journal of Pediatrics}} 7 4 , year={2011} } @incollection{b6, , title={{Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children}} , author={{ HWhittle } and { SJaffar } and { MWansbrough } and { MMendy } and { UDumpis } and { ACollinson } and { AHall }} , journal={{Bmj}} 325 7364 569 , year={2002} } @incollection{b7, , title={{Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children}} , author={{ Dy-KBut } and { C-LLai } and { W-LLim } and { JFung } and { Dk-HWong } and { M-FYuen }} , journal={{Vaccine}} 26 51 , year={2008} } @incollection{b8, , title={{Long-term protection of hepatitis B vaccine 18 years after vaccination}} , author={{ FAlfaleh } and { SAlshehri } and { SAlansari } and { MAljeffri } and { YAlmazrou } and { AShaffi } and { AAAbdo }} , journal={{Journal of Infection}} 57 5 , year={2008} } @book{b9, , title={{WHO: Hepatitis B vaccines}} , year={1999} , address={Geneva} } @book{b10, , title={{Evaluation of the routine hepatitis B immunization programme in Palestine}} , author={{ SKuhail } and { REl Khodary } and { AhmedF }} , year={1996. 2000} } @incollection{b11, , title={{Immunogenicity of Cuban hepatitis B vaccine in Iranian children}} , author={{ HDahifar }} , journal={{Arch Iranian Med}} 7 2 , year={2004} } @incollection{b12, , title={{The nonresponse to hepatitis B vaccination is associated with impaired lymphocyte activation}} , author={{ LGoncalves } and { BAlbarran } and { SSalmen } and { LBorges } and { HFields } and { HMontes } and { ASoyano } and { YDiaz } and { LBerrueta }} , journal={{Virology}} 326 1 , year={2004} } @incollection{b13, , title={{Diminished Th1 and Th2 cytokine production in healthy adult nonresponders to recombinant hepatitis B vaccine}} , author={{ GKardar } and { MJeddi-Tehrani } and { FShokri }} , journal={{Scandinavian journal of immunology}} 55 3 , year={2002} }